Natalizumab wearing-off symptoms: effect of extend interval dosing during Sars-CoV-2 pandemic-Reference-Cited by-同舟云学术

Natalizumab wearing-off symptoms: effect of extend interval dosing during Sars-CoV-2 pandemic

Published:2022-10-13 Issue:2 Volume:270 Page:595-600
ISSN:0340-5354
Container-title:Journal of Neurology
language:en
Short-container-title:J Neurol

Author:

Magro Giuseppe^ORCID,Barone Stefania,Tosto Federico,De Martino Antonio,Santange lo Domenico,Manzo Lucia^ORCID,Pascarella Angelo^ORCID,Bruno Pietro,Pasquale Marilisa,Gambardella Antonio,Valentino Paola^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),Neurology

Link

https://link.springer.com/content/pdf/10.1007/s00415-022-11408-0.pdf

Reference29 articles.

1. Rudick RA, Stuart WH, Calabresi PA et al (2006) Natalizumab plus interferon beta-1a for relapsing multiple sclerosis. N Engl J Med 354:911–923

2. Sehr T, Proschmann U, Thomas K et al (2016) New insights into the pharmacokinetics and pharmacodynamics of natalizumab treatment for patients with multiple sclerosis, obtained from clinical and in vitro studies. J Neuroinflammation 13:164

3. Rudick RA, Sandrock A (2004) Natalizumab: alpha 4-integrin antagonist selective adhesion molecule inhibitors for MS. Expert Rev Neurother 4:571–580

4. Khatri BO, Man S, Giovannoni G et al (2009) Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function. Neurology 72:402–409

5. Clerico M, De Mercanti SF, Signori A et al (2020) Extending the interval of natalizumab dosing: is efficacy preserved? Neurother J Am Soc Exp Neurother 17:200–207

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of personalized extended interval dosing on the natalizumab wearing-off effect - a sub-study of the NEXT-MS trial;Journal of the Neurological Sciences;2024-07

2. Treatment modifiers across different regimens of natalizumab treatment in MS: An Italian real-world experience;Neurotherapeutics;2024-04

3. Natalizumab extended-interval dosing in a real-life setting;Journal of the Neurological Sciences;2023-07